KPCPY yields 6.34% · PFE yields 6.20%● Live data
📍 KPCPY pulled ahead of the other in Year 1
Combined, KPCPY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KPCPY + PFE for your $10,000?
Kasikornbank Public Company Limited, together with its subsidiaries, provides commercial banking products and services in Thailand and internationally. The company's personal banking products and services include savings, current, fixed deposit, and foreign currency accounts; personal, home, and auto loans; debit and credit cards; life and non-life insurance products; investment products, such as mutual funds, stocks, and derivatives/futures exchange; money transfer and bill payment, cheque and draft, and foreign exchange services; and digital banking services. It also offers various products and services for small and medium enterprises, including savings, current, and fixed deposits; working capital, commercial, and special loans, as well as letters of guarantee; collection and payment services; life, non-life, and group insurance products; and import, export, and money transfer services. In addition, the company provides various products and services for corporate customers, such as cash management solutions, including current, savings, special savings deposit, and fixed deposit accounts, as well as collection, payment, liquidity management, and electronic service solutions; international trade solutions comprising import and export, global money transfer, guarantee, and trade finance solutions; working capital loans, term loans, special loans, and letters of guarantee; supply chain financing; life, non-life, and group insurance products; and foreign exchange and derivatives, corporate finance, securities, investment, and business card services. Further, it offers auto and equipment leasing, and venture capital management services. The company operates 839 branches. Kasikornbank Public Company Limited was founded in 1945 and is headquartered in Bangkok, Thailand.
Full KPCPY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.